An interventional study of Reporting of patient reported outcome measures in Rheumatoid Arthritis and Axial Spondyloarthritis, sponsored by Henrik Gudbergsen. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-02-08.
Sponsored by Henrik Gudbergsen · Not applicable, Interventional, and Other
To investigate if electronic reporting of patient reported outcome measures from home is comparable to the traditional touch-screen solution to hospital among patients with rheumatoid arthritis and axial spondyloarthritis
623 studies on the registry are indexed under Spondylitis; 83 are open to participants now.
This study's enrollment of 42 is below the median of 92 across 349 interventional studies indexed under Spondylitis.
Browse Spondylitis studies →Henrik Gudbergsen is the lead sponsor of 10 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria
Patients in this arm (10 patients with rheumatoid arthirtis, RA) will be randomised to initially fill in patient reported outcome measures from home via their own computer or tablet; subsequently these patients will fill in patient reported outcome measures at the outpatient clinic
Other: Reporting of patient reported outcome measures
Patients in this arm (10 patients with rheumatoid arthirtis, RA) will be randomised to initially fill in patient reported outcome measures at the outpatient clinic; subsequently these patients will fill in patient reported outcome measures from home via their own computer or tablet
Other: Reporting of patient reported outcome measures
Patients in this arm (10 patients with axial spondyloarthritis, AxSpa) will be randomised to initially fill in patient reported outcome measures from home via their own computer or tablet; subsequently these patients will fill in patient reported outcome measures at the outpatient clinic
Other: Reporting of patient reported outcome measures
Patients in this arm (10 patients with axial spondyloarthritis, AxSpa) will be randomised to initially fill in patient reported outcome measures at the outpatient clinic; subsequently these patients will fill in patient reported outcome measures from home via their own computer or tablet
Other: Reporting of patient reported outcome measures
Electronic reporting of patient reported outcome measures from home, compared to reporting of patient reported outcome measures at the outpatient clinic
HAQ
The Health Assessment Questionnaire (HAQ) developed to retrieve quantitative information on outcomes among patients with rheumatoid arthritis
Time frame: 48 hours
100 mm VAS global
Assessed via a visual analogue scale (VAS)
Time frame: 48 hours
100 mm VAS pain
Assessed via a visual analogue scale (VAS)
Time frame: 48 hours
100 mm VAS fatigue
Assessed via a visual analogue scale (VAS)
Time frame: 48 hours
BASDAI
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) developed to retrieve quantitative information on outcomes among patients with Ankylosing Spondylitis
Time frame: 48 hours
BASFI
The Bath Ankylosing Spondylitis Functional Index (BASFI) developed to retrieve quantitative information on outcomes among patients with Ankylosing Spondylitis
Time frame: 48 hours
BASDAI 5 & 6
Questions 5 and 6 in BASDAI
Time frame: 48 hours
Smoking questionnaire
Smoking habits (I currently smoke; if smoking, then how many cigarettes, pibes, cigarillos, cigars and/or cheroots per day / I smoke from time to time; less than 1 cigarettes, or an equivalent amount, per day / I have stopped smoking; year of cessation / I have never smoked)
Time frame: 48 hours
Alcohol consumption (units consumed per week)
Time frame: 48 hours
Exercise questionnaire
Level of exercise; "exercise that causes an increased pulse and/or a feeling of being breathless" (5 times per week / 3-4 times per week / 1-2 times per week / 1-2 times per month / no regular exercising / I do not exercise)
Time frame: 48 hours
Medical conditions questionnaire
Diagnosis of other medical conditions; "Has a doctor ever said that you have or have had the following diseases?" (hypertension / diabetes / tuberculosis / angina / hypercholesterolemia / heart attack / brain haemorrhage / asthma / psoriasis / chronic bronchitis / osteoporosis / ulcer / liver disease / kidney disease / depression / inflammatory bowel disease or Crohns disease / cancer / multiple sclerosis / thyroid disease)
Time frame: 48 hours
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Henrik Gudbergsen